# Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users

> **NCT02070692** · PHASE4 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 56 (actual)

## Conditions studied

- Menstruation Disturbances

## Interventions

- **DRUG:** Tamoxifen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02070692
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2017-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02070692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02070692, "Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02070692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*